Baraona E, Finkelman F, Matsuda Y, Lieber C S
Anal Biochem. 1983 Apr 15;130(2):302-10. doi: 10.1016/0003-2697(83)90592-4.
The usual measurement of liver tubulin by the colchicine-binding assay does not take into account the accelerated decay of the colchicine-binding capacity of tubulin when liver supernatants, especially those containing microtubule-derived tubulin, are incubated at 37 degrees C. This results in marked underestimations. Our findings indicate that this alteration is due to an inhibitor of colchicine-tubulin binding in liver supernatants that is probably extracted from particulate fractions. The inhibitory activity is decreased by dilution of the supernatants and by increasing the concentration of colchicine. However, the former modification decreases the sensitivity of the assay and the latter increases the nonspecific binding of colchicine to liver proteins other than tubulin. Assessment of the decay and correction for it by calculating the initial binding capacity results in complete recovery of brain tubulin from liver supernatants and values for microtubule-derived tubulin that closely correspond to those expected from simultaneous morphometric assessment of liver microtubules by electron microscopy. The modified method also indicates that the fraction of liver tubulin assembled in microtubules is greater than previously reported.
通常通过秋水仙碱结合试验对肝微管蛋白进行的测量,未考虑到当肝上清液(尤其是那些含有源自微管的微管蛋白的上清液)在37℃孵育时,微管蛋白秋水仙碱结合能力的加速衰减。这导致明显的低估。我们的研究结果表明,这种改变是由于肝上清液中一种秋水仙碱 - 微管蛋白结合抑制剂所致,该抑制剂可能是从颗粒部分提取的。通过稀释上清液和增加秋水仙碱浓度可降低抑制活性。然而,前一种改良降低了试验的灵敏度,而后一种则增加了秋水仙碱与除微管蛋白之外的肝蛋白的非特异性结合。通过计算初始结合能力来评估衰减并对其进行校正,可从肝上清液中完全回收脑微管蛋白,并且源自微管的微管蛋白的值与通过电子显微镜对肝微管进行同步形态计量评估所预期的值密切对应。改良后的方法还表明,组装在微管中的肝微管蛋白比例高于先前报道的比例。